John Tomayko

1.0k citations

18 papers · 763 indexed · h-index 14

Impact in

Applied Microbiology and Biotechnology top 2%
- Antibiotic Use and Resistance
Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Molecular Medicine 10
- Antibiotic Resistance in Bacteria 10
Endocrinology 4
- Escherichia coli research studies 2

Co-authors: Barbara E. Murray (3 shared papers)Steven C. Ricke (1 shared paper)Teresa M. Coque (1 shared paper)B E Murray (3 shared papers)Aaron Dane (3 shared papers)Mark Goldberger (3 shared papers)John Rex (3 shared papers)Barry I. Eisenstein (3 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (8 papers)Journal of Clinical Microbiology (2 papers)Advances in Skin & Wound Care (2 papers)Clinical Infectious Diseases (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

John Tomayko

18 papers receiving 718 citations

Peers

Countries citing papers authored by John Tomayko

Since Specialization

Citations

This map shows the geographic impact of John Tomayko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tomayko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tomayko more than expected).

Fields of papers citing papers by John Tomayko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Tomayko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tomayko. The network helps show where John Tomayko may publish in the future.

Co-authors

The 25 scholars most cited alongside John Tomayko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Tomayko Line = papers co-authored together John Tomayko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States Antimicrobial Agents and Chemotherapy ·Teresa M. Coque, John Tomayko, Steven C. Ricke, P C Okhyusen, Barbara E. Murray	1996	221
2	A comprehensive regulatory framework to address the unmet need for new antibacterial treatments The Lancet Infectious Diseases ·John Rex, Barry I. Eisenstein, Jeff Alder, Mark Goldberger, Robert Meyer, Aaron Dane, Ian R. Friedland, Charles Knirsch, Wendy R. Sanhai, John Tomayko, Cindy Lancaster, Jennifer Jackson	2013	92
3	Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections Antimicrobial Agents and Chemotherapy ·Karen O’Dwyer, Aaron Spivak, Karen Ingraham, Sharon Min, David Holmes, Charles Jakielaszek, Stephen Rittenhouse, Alan L. Kwan, George P. Livi, Ganesh M. Sathe, E. S. Thomas, Stephanie Van Horn, Linda A. Miller, Monique Twynholm, John Tomayko, Marybeth Dalessandro, Madelyn M. Caltabiano, Nicole E. Scangarella-Oman, James R. Brown	2014	73
4	Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial Critical Care Medicine ·R. Phillip Dellinger, John Tomayko, Derek C. Angus, Steven M. Opal, Michael Cupo, Sharon McDermott, Annie Ducher, Thierry Calandra, Jonathan B. Cohen	2009	53
5	Progress in the Fight Against Multidrug-Resistant Bacteria 2005–2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance Clinical Infectious Diseases ·John Rex, George H. Talbot, Mark Goldberger, Barry I. Eisenstein, Roger Echols, John Tomayko, Michael N. Dudley, Aaron Dane	2017	47
6	Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis Journal of Clinical Microbiology ·John Tomayko, B E Murray	1995	44
7	Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects Antimicrobial Agents and Chemotherapy ·Paul B. Eckburg, Troy Lister, Susannah M. Walpole, Tim Keutzer, Luke Utley, John Tomayko, Ellen Kopp, Nicholas Farinola, Scott Coleman	2019	41
8	Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents Antimicrobial Agents and Chemotherapy ·Matthew L. Rizk, Sujata M. Bhavnani, George L. Drusano, Aaron Dane, Ann E. Eakin, Tína Guina, Suk‐Chan Jang, John Tomayko, Jie Wang, Luning Zhuang, Thomas P. Lodise	2019	37
9	Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis Antimicrobial Agents and Chemotherapy ·John Tomayko, K K Zscheck, Kavindra V. Singh, B E Murray	1996	24
10	Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic Drug Metabolism and Disposition ·Gary D. Bowers, David M. Tenero, Parul Patel, Phuong Tu Huynh, James Sigafoos, Kathryn O’Mara, Graeme Young, Étienne Dumont, Elizabeth Cunningham, Milena Kurtinecz, Patrick Stump, J. J. Conde, John P. Chism, Melinda J. Reese, Yun Lan Yueh, John Tomayko	2013	23
11	Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci Antimicrobial Agents and Chemotherapy ·Volkan Korten, John Tomayko, Barbara E. Murray	1994	22
12	Systematic Review and Meta-Analysis of Antimicrobial Treatment Effect Estimation in Complicated Urinary Tract Infection Antimicrobial Agents and Chemotherapy ·Krishan Singh, Gang Li, Fanny S Mitrani-Gold, Milena Kurtinecz, Jeffrey D. Wetherington, John Tomayko, Linda M. Mundy	2013	22
13	Intrapulmonary Pharmacokinetics of GSK2251052 in Healthy Volunteers Antimicrobial Agents and Chemotherapy ·David M. Tenero, Gary D. Bowers, Keith A. Rodvold, Apurva R. Patel, Milena Kurtinecz, Étienne Dumont, John Tomayko, Parul Patel	2013	18
14	Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period Journal of Clinical Microbiology ·Prema Seetulsingh, John Tomayko, P E Coudron, Sheldon M. Markowitz, Cindy Skinner, Kavindra V. Singh, B E Murray	1996	16
15	The Challenge of Antimicrobial Resistance: New Regulatory Tools to Support Product Development Clinical Pharmacology & Therapeutics ·John Tomayko, John Rex, David M. Tenero, Mark Goldberger, Barry I. Eisenstein	2014	13
16	A Randomized, Double-blind, Comparative Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment 1% Versus Oral Linezolid in the Treatment of Secondarily Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Advances in Skin & Wound Care ·Tonny Tanus, Nicole E. Scangarella-Oman, Marybeth Dalessandro, Gang Li, John Breton, John Tomayko	2014	9
17	The Safety and Efficacy of Topical Retapamulin Ointment Versus Placebo Ointment in the Treatment of Secondarily Infected Traumatic Lesions Advances in Skin & Wound Care ·John Tomayko, Gang Li, John Breton, Nicole E. Scangarella-Oman, Marybeth Dalessandro, Michael Martin	2013	6
18	DU-6859a, a new fluoroquinolone agent comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli Diagnostic Microbiology and Infectious Disease ·John Tomayko, Volkan Korten, Barbara E. Murray	1994	2

About John Tomayko

John Tomayko is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Infectious Diseases and Pharmacology, having authored 18 papers that have together received 763 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Urinary Tract Infections Management (2 papers), Pneumonia and Respiratory Infections (2 papers), Infective Endocarditis Diagnosis and Management (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Escherichia coli research studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Molecular Medicine (234 citations), Clinical Biochemistry (196 citations), Infectious Diseases (327 citations) and Microbiology (53 citations). John Tomayko has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Barbara E. Murray, Steven C. Ricke, Teresa M. Coque, B E Murray, Aaron Dane, Mark Goldberger, John Rex, Barry I. Eisenstein, Robert Meyer and Charles Knirsch. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Advances in Skin & Wound Care, Clinical Infectious Diseases and Diagnostic Microbiology and Infectious Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact